ARDELYX, INC. — Director's Dealing 2023

Nov 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2023-11-15

Reporting Person: Williams Laura A (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-15	Common Stock	S	25000	$3.9999	Disposed	266839	Direct

Footnotes

F1: This transaction was executed in multiple trades in prices ranging from $3.97 to $4.045, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.